|
|
|
|
|
|
|
National Conference • July 10 - 12, 2006
Seminars • July 10, 2006
InterContinental Mark Hopkins Hotel
San Francisco, California
Drug benefit costs continue to rise as health plans and employers struggle to manage this benefit that has outpaced overall medical benefit trends. In fact, prescription drugs represent the single most costly factor driving up health care costs for employees. Trend will continue to rise as new, expensive drugs are introduced and the population ages, however there are ways to meet these challenges head-on. Direct costs cannot be looked at in a vacuum and the value of drugs, the outcomes and impact on long-term health of employees also need to be considered when developing the pharmacy benefit.
The new Medicare Prescription Part D Benefit creates even more reason and urgency for health plans and employers to develop new and innovative strategies for management of the pharmaceutical benefit while maintaining clinically appropriate access, efficient delivery and affordable costs for those that utilize the benefit the most.
The World Congress is proud to present the Executive Forum on Rx Benefit Management taking place July 10 - 12, 2006 at the Mark Hopkins Hotel in San Francisco. The Forum will showcase how payers are responding to the rising cost of pharmaceuticals with creative new strategies. The Forum will help identify the most pertinent issues for plans to address in the coming year that include providing benefits to diverse populations, adapting to market shifts with consumer-directed initiatives and measuring the impact of existing pharmacy management programs. Additionally, the event will highlight how employers are beginning to identify strategies through drug benefit design to lower medical costs, improve health, lower absenteeism and increase employee productivity.
The Rx Benefit Management Forum 2006 will help senior executives from employers, health plans and government:
- Evaluate current drug trends and develop a comprehensive strategy to contain costs and spending
- Understand the growing area of specialty drug utilization, the impact on patient outcomes and develop effective programs to address the trend
- Apply recent government guidelines, legislation and changes regarding Medicare Part D benefits
- Learn the value of the innovative prescription benefit design and the impact on chronic disease outcomes
- Hear the Pros and Cons of developing an in-house pharmacy program versus outsourcing the benefit
- Understand the growing trend of specialty drug benefits and the impact and value on patient outcomes
- Determine appropriate utilization rates and accurately forecast pharmacy spend
- Benchmark drug plan design against peer organizations, and avoid mistakes others have made while testing programs
Featuring New Research from:
|
|
| |
|
|
|
|
|
|
|
Dee Edington, PhD
Professor, Division of Kinesiology; Director, Health Management
Research Center
University of Michigan
|
| |
|
|
A.Mark Fendrick, MD
Professor, Internal Medicine and Health Management & Policy
University of Michigan School of Medicine
Co-Editor in Chief
American Journal of Managed Care
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
